Skip to main content

Table 3 Treatment pathways by route of administration

From: Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis

 

DMT-treated patients

First Treatment Course

Oral

Injectable

Infusion

Second DMT treatment course

 n

7510

 

541

 

6898

 

71

 

Route of administration (n, %)

 Oral

2247

29.9

423

78.2

1799

26.1

25

35.2

 Injectable

5119

68.2

106

19.6

4993

72.4

20

28.2

 Infusion

144

1.9

12

2.2

106

1.5

26

36.6

Restart first DMT (n, %)

3843

51.2

268

49.5

3555

51.5

20

28.2

Third DMT treatment course

 n

3882

 

200

 

3645

 

37

 

Route of administration (n, %)

 Oral

1234

31.8

149

74.5

1067

29.3

18

48.6

 Injectable

2587

66.6

47

23.5

2530

69.4

10

27.0

 Infusion

61

1.6

4

2.0

48

1.3

9

24.3

Restart second DMT (n, %)

2325

59.9

115

57.5

2194

60.2

16

43.2